glp-1 for cats A biopharmaceutical company is looking ways to slim down household pets. Okava Pharmaceuticals, a San Francisco based company, is introducing a new clinical weight loss study for cats. MEOW-1, as Clinical trial evaluates GLP-1 for

Novo Nordisk is evaluating a long-acting semaglutide implant designed to keep GLP-1 patients on treatment for months at a time and food and drink manufacturers should be watching closely.

Loss of muscle mass and strength not only impairs mobility and quality of life, but also worsens insulin resistance, accelerates cardiometabolic decline and increases mortality risk

The consistent, substantial kidney and cardiovascular benefits of these agents has led to their incorporation into professional guidelines as foundational care for type 2 diabetes

Discover what foods make you sick on semaglutide and why

I ordered GLP-1s from Noom, reviewed the program myself, and scored it 69/100

Please consult your doctor before starting any exercise or nutritional supplement program or before using these or any product during pregnancy or if you have a serious medical condition